Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Schedule an appointment today
Call to Schedule: 1-866-UH4-CARE
Find University Hospitals Doctors
Anthony Post, MD

Anthony Post, MD

  • Medical Director, Liver Transplantation, UH Cleveland Medical Center
  • Associate Professor, CWRU School of Medicine
  • Specialty: Hepatology
  • Location:
    UH Cleveland Minoff Health Center
    3909 Orange Pl
    Beachwood, OH 44122

Biography: Anthony Post, MD

Expertise

  • Gastrointestional Cancer
  • Hepatitis
  • Hepatology
  • Liver Cancers
  • Liver Disease
  • Liver Transplantation
  • Transplant Evaluation

Certifications & Memberships

  • Transplant Hepatology - American Board of Internal Medicine
  • Gastroenterology - American Board of Internal Medicine
  • Internal Medicine - American Board of Internal Medicine

Education

Fellowship | Gastroenterology
Gastroenterology - Cleveland Clinic (1989 - 1991)

Residency | Internal Medicine
Internal Medicine - University Hospitals Of Cleveland (1987 - 1989)

Internship | Internal Medicine
Internal Medicine - University Hospitals Of Cleveland (1986 - 1987)

Medical Education
Case Western Reserve University School Of Medicine (1986)

Professional Education
Case Western Reserve University (1983)

Undergraduate
Oberlin College (1979)

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Anthony Post disclosed the following Outside Relationships with Industry:

  • - Amgen - Ownership
  • - Gilead Pharmacuticals - Honoraria